Found 4 articles for: "epidermolysis bullosa"
An Update on Common Genodermatoses Not to be Missed
July 2026 | Volume 25 | Issue 7 | Features | 673 | Copyright © July 2026
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib
April 2026 | Volume 25 | Issue 4 | Case Reports | 384 | Copyright © April 2026
Introduction: JAK inhibitors are increasingly being utilized for the treatment of diseases beyond their nonclassical indications, and thehighly selective JAK1 inhibi...
Read MoreRituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature
April 2025 | Volume 24 | Issue 4 | Original Article | 387 | Copyright © April 2025
Read MoreDiacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial
June 2023 | Volume 22 | Issue 6 | Original Article | 599 | Copyright © June 2023
Background: In epidermolysis bullosa simplex (EBS), epithelial structural fragility results in blisters and erosions. Diacerein 1% ointment has been shown to reduce this blisteri...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
